Physician profile
Henry G Yip
NPI 1295361202
$979.32
in general payments reported to CMS, 2019-2025
19 companies · $960 in 2025
The $960 reported for 2025 was more than what 77% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $19.78 · 2025: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977 · Education: $2.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.94 |
| Education | $2.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $166.19 | 2025 | Rayaldee |
| Travere Therapeutics, INC. | $101.86 | 2025 | Filspari |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.81 | 2024-2025 | Jardiance |
| Lilly USA, LLC | $73.18 | 2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $71.59 | 2025 | Jynarque, Voyxact |
| Renalytix Ai, INC. | $60.01 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Puma Biotechnology, INC. | $50.94 | 2025 | |
| Amgen INC. | $45.95 | 2025 | Krystexxa |
| Novo Nordisk INC | $39.07 | 2025 | Rybelsus, Ozempic |
| Mallinckrodt Hospital Products INC. | $37.33 | 2025 | Acthar |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $36.55 | 2025 | Voyxact |
| Abbvie INC. | $34.58 | 2025 | |
| Pfizer INC. | $32.42 | 2025 | |
| Alexion Pharmaceuticals, INC. | $29.03 | 2025 | Ultomiris |
| Vifor Pharma, INC. | $27.12 | 2025 | Veltassa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $24.50 | 2025 | Lupkynis |
| Ardelyx, INC. | $24.00 | 2025 | Ibsrela |
| Novartis Pharmaceuticals Corporation | $23.82 | 2025 | |
| Fresenius USA Manufacturing, INC. | $22.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Yip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.